Inactive Instrument

Highlights PERRIGO TEL AVIV STOCK EXCHANGE

Equities

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

06-13	Piper Sandler Adjusts Price Target on Perrigo to $36 From $39, Maintains Overweight Rating	MT
06-11	Transcript : Perrigo Company plc Presents at Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference, Jun-11-2024 01:30 PM

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day	05-30	FA
Perrigo's Q1 Adjusted Earnings, Net Sales Drop	05-07	MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B	05-07	MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23	05-07	MT
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024	05-07	CI
Perrigo Company plc Reaffirms Earnings Guidance Year 2024 and Provides Sales Guidance for the Second Half of 2024	05-07	CI
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31	05-01	MT
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024	05-01	CI
Sector Update: Health Care Stocks Decline Late Afternoon	04-25	MT
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	04-25	MT
Esteve Healthcare S.L. signed a binding offer to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc for approximately ?280 million.	04-24	CI
Multiple CVS Caremark Plans Reportedly to Cover Perrigo's Opill at No Cost	04-04	MT
Sector Update: Health Care Stocks Rise Late Afternoon	03-19	MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	03-19	MT
Perrigo Shares Rise After Wisconsin Governor Makes Birth Control Pill Free for Medicaid Members	03-19	MT
Ex-dividend day	03-06	FA
Perrigo Company plc Commences Shipments of Opill to Retailers Nationwide, Empowering Millions to Enter A New Era of Reproductive Health Access in the United States	03-04	CI
Perrigo Company plc Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Perrigo Q4 Adjusted Earnings Increase, Net Sales Flat	02-27	MT
Earnings Flash (PRGO) PERRIGO COMPANY Reports Q4 Revenue $1.16B, vs. Street Est of $1.17B	02-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PERRIGO TEL AVIV STOCK EXCHANGE

Equities

Highlights

Filters